Clinical Trial: A Phase ?b Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Tumor Infiltrating Lymphocytes
Study Type: INTERVENTIONAL
Official Title: An Open, Single-armed, Phase Ib Study to Evaluate the Safety and Efficacy Using Autologous TIL in Patients With Advanced Melanoma
Brief Summary:
20 participants are expected to be enrolled for the Phase Ib clinical trial?this trail is expected to be finished in 20 months.
Read more